Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-09-06
2005-09-06
Wang, Shengjun (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S310000, C514S317000, C514S327000, C514S468000, C514S561000
Reexamination Certificate
active
06939876
ABSTRACT:
The present invention provides a composition for treating pain. The composition includes a pharmaceutically acceptable analgesic and a GABAergic agent, such as gamma vinyl GABA, effective in reducing or eliminating the addictive liability of the analgesic. The invention also includes a method for reducing or eliminating the addictive
REFERENCES:
patent: 6057368 (2000-05-01), Dewey et al.
patent: 6541520 (2003-04-01), Dewey et al.
patent: 6593367 (2003-07-01), Dewey et al.
Astramorph in PDR, 50thEd., 1996, 535-536.
Ashby, Jr. Charles R.
Brodie Jonathan D.
Dewey Stephen L.
Bogosian Margaret C.
Brookhaven Science Associates LLC
Wang Shengjun
LandOfFree
Prevention of addiction in pain management does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prevention of addiction in pain management, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prevention of addiction in pain management will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3392656